Feener Edward P. (CIK 0001691090)

Latest company ownership

Role: CHIEF SCIENTIFIC OFFICER
Shares held
7,292
Last filed at
May 21, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 17, 2024 May 21, 2024 KalVista Pharmaceuticals, Inc. CHIEF SCIENTIFIC OFFICER Sell 42.5 -8,088 -9.99% $95.2K
Feb 17, 2024 Feb 21, 2024 KalVista Pharmaceuticals, Inc. CHIEF SCIENTIFIC OFFICER Sell 7.5 -28,288 -31.28% $397.9K
Feb 14, 2024 Feb 16, 2024 KalVista Pharmaceuticals, Inc. CHIEF SCIENTIFIC OFFICER Sell 40.0 -28,171 -28.22% $422.8K
Jan 11, 2024 Jan 12, 2024 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 7.5 -22,679 -36.28% $295.5K
Jan 8, 2024 Jan 10, 2024 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 15.0 -17,321 -21.70% $225.3K
Nov 17, 2023 Nov 21, 2023 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 46.3 -4,958 -5.85% $40.8K
Aug 17, 2023 Aug 21, 2023 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -4,976 -6.36% $53.4K
May 17, 2023 May 19, 2023 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 46.3 -1,786 -2.61% $18.1K
Feb 17, 2023 Feb 23, 2023 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 46.3 -2,228 -3.35% $17.1K
Nov 17, 2022 Nov 21, 2022 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 50.0 -530 -0.84% $2.9K
Aug 17, 2022 Aug 19, 2022 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 50.0 -532 -0.86% $8K
Nov 1, 2021 Nov 3, 2021 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 10.0 -6,000 -72.87% $108.4K
Aug 2, 2021 Aug 4, 2021 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 10.0 -6,000 -42.15% $123.1K
Jun 1, 2021 Jun 3, 2021 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 7.5 -34,000 -70.49% $908.4K
May 3, 2021 May 7, 2021 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 25.0 -6,000 -11.06% $149.1K
May 3, 2021 May 6, 2021 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 28.8 -6,000 -9.96% $149.1K
Feb 23, 2021 Feb 25, 2021 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 5.0 -31,000 -36.37% $1M
Nov 2, 2020 Nov 4, 2020 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 28.8 -6,000 -7.62% $102.8K
Oct 20, 2020 Oct 22, 2020 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 17.5 -16,907 -17.68% $303K
Oct 16, 2020 Oct 20, 2020 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 48.8 -993 -1.03% $16.9K
Feb 5, 2020 Feb 7, 2020 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 55.0 -100 -0.10% $1.7K
Jul 22, 2019 Jul 24, 2019 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 37.5 -3,300 -3.30% $61.4K
Apr 17, 2019 Apr 18, 2019 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 37.5 -4,000 -3.84% $99.7K
Jan 16, 2019 Jan 18, 2019 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 37.5 -4,000 -3.70% $78.2K
Sep 18, 2018 Sep 20, 2018 KalVista Pharmaceuticals, Inc. Chief Scientific Officer Sell 91.3 +10,000 10.20% $42.6K